Home › Funds › MH & ASSOCIATES SECURITIES MANAGEMENT CORP /ADV › VKTX
MH & ASSOCIATES SECURITIES MANAGEMENT CORP /ADV position in VKTX
VIKING THERAPEUTICS INC · Health Care
MH & ASSOCIATES SECURITIES MANAGEMENT CORP /ADV reported holding 65,385 shares of VKTX (VIKING THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$2.1M, representing 1.86% of its reported portfolio and ranking #29 among its reported holdings. MH & ASSOCIATES SECURITIES MANAGEMENT CORP /ADV has disclosed VKTX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-10-30 · Source: SEC EDGAR Form 13F-HR
How MH & ASSOCIATES SECURITIES MANAGEMENT CORP /ADV's VKTX position evolved
MH & ASSOCIATES SECURITIES MANAGEMENT CORP /ADV first disclosed a stake in VKTX in Q4 2025 at 43,634 shares (US$1.5M). The position peaked in Q2 2026 at 65,180 shares, worth US$2.5M. Across 4 filings, MH & ASSOCIATES SECURITIES MANAGEMENT CORP /ADV increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 65,385 shares valued at US$2.1M. Notable position changes include a 50% increase in Q1 2026 (shares rose 20% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 43.63K | $1.54M | New |
| Q1 2026 | 65.42K | $2.13M | Add |
| Q2 2026 | 65.18K | $2.54M | Hold |
| Q3 2026 | 65.39K | $2.13M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About VKTX and 13F data
VKTX (VIKING THERAPEUTICS INC) is a Health Care company. 35 other funds we track also report a position in VKTX — the largest reported positions include Vestal Point Capital, LP (US$26.5M), Eversept Partners, LP (US$23.5M), ADAR1 Capital Management, LLC (US$22.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding VKTX
- Vestal Point Capital, LP 680.00K sh · $26.53M · Q2 2026
- Eversept Partners, LP 602.92K sh · $23.52M · Q2 2026
- ADAR1 Capital Management, LLC 574.04K sh · $22.39M · Q2 2026
- TANG CAPITAL MANAGEMENT LLC 500.00K sh · $19.50M · Q2 2026
More on MH & ASSOCIATES SECURITIES MANAGEMENT CORP /ADV
FAQ
How long has MH & ASSOCIATES SECURITIES MANAGEMENT CORP /ADV held VKTX?
MH & ASSOCIATES SECURITIES MANAGEMENT CORP /ADV has disclosed VKTX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is MH & ASSOCIATES SECURITIES MANAGEMENT CORP /ADV's current position in VKTX?
As of Q3 2026, MH & ASSOCIATES SECURITIES MANAGEMENT CORP /ADV holds 65.39K shares of VKTX (VIKING THERAPEUTICS INC), valued at $2.13M, representing 1.86% of its reported portfolio and ranking #29.
Has MH & ASSOCIATES SECURITIES MANAGEMENT CORP /ADV been buying or selling VKTX?
In the latest 13F filing (Q3 2026), MH & ASSOCIATES SECURITIES MANAGEMENT CORP /ADV held unchanged its position in VKTX. The position peaked in Q2 2026 at 65.18K shares.
Which other funds hold VKTX?
Other major institutional holders of VKTX include Vestal Point Capital, LP, Eversept Partners, LP, ADAR1 Capital Management, LLC, among 35 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.